Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)

CNY 4.19

(-0.48%)

Market Cap (In CNY)

7.71 Billion

Revenue (In CNY)

6.46 Billion

Net Income (In CNY)

287.23 Million

Avg. Volume

11.92 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.86-4.68
PE
-
EPS
-
Beta Value
0.515
ISIN
CNE100000NG5
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Lingzhong Kong
Employee Count
-
Website
https://www.xinbang.com
Ipo Date
2010-04-16
Details
Guizhou Xinbang Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of Chinese herbal medicines and biological drugs in China and internationally. It offers cardiovascular and cerebrovascular, digestive system, endocrine, tumor and immune regulation, blood system, rheumatism and rheumatoid, urinary system, antipyretic analgesic, cold medication, gynecological treatment, and anti-infective drugs. The company was founded in 1995 and is headquartered in Guiyang, China.